The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (e)(1)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=tpb_AwardsGranted20220314Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=tpb_AwardsGranted20220429Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=tpb_AwardsGranted20230505Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=tpb_AwardsGranted20240301Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=tpb_AwardsGranted20240401Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=tpb_AwardsGranted20240508Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=tpb_AwardsGranted20250303Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=tpb_AwardsGranted20250305Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Note 13 - Share Incentive Plans - Summary of Restricted Stock Units (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares									3 Months Ended
	Mar. 05, 2025	Mar. 03, 2025	May 08, 2024	Apr. 01, 2024	Mar. 01, 2024	May 05, 2023	Apr. 29, 2022	Mar. 14, 2022	Mar. 31, 2025
Equity instruments outstanding (in shares)									186,669
Awards Granted 20220314 [Member]
Number of instruments granted (in shares)								50,004
Equity instruments outstanding (in shares)									21,113
Fair value as of grant date (in dollars per share)									$ 30.46
Remaining lives (Year)									1 year 9 months
Awards Granted 20220429 [Member]
Number of instruments granted (in shares)							4,522
Equity instruments outstanding (in shares)									1,263
Fair value as of grant date (in dollars per share)									$ 31.39
Remaining lives (Year)									1 year 9 months
Awards Granted 20230505 [Member]
Number of instruments granted (in shares)						130,873
Equity instruments outstanding (in shares)									34,564
Fair value as of grant date (in dollars per share)									$ 22.25
Remaining lives (Year)									1 year
Awards Granted 20240301 [Member]
Number of instruments granted (in shares)					105,257
Equity instruments outstanding (in shares)									57,433
Fair value as of grant date (in dollars per share)									$ 26.52
Remaining lives (Year)									2 years
Awards Granted 20240401 [Member]
Number of instruments granted (in shares)				5,495
Equity instruments outstanding (in shares)									3,627
Fair value as of grant date (in dollars per share)									$ 29.12
Remaining lives (Year)									2 years
Awards Granted 20240508 [Member]
Number of instruments granted (in shares)			16,905
Equity instruments outstanding (in shares)									16,905
Fair value as of grant date (in dollars per share)									$ 33.13
Remaining lives (Year)									3 months
Awards Granted 20250303 [Member]
Number of instruments granted (in shares)		36,843
Equity instruments outstanding (in shares)									36,843
Fair value as of grant date (in dollars per share)									$ 70.34
Remaining lives (Year)									3 years
Awards Granted 20250305 [Member]
Number of instruments granted (in shares)	14,921
Equity instruments outstanding (in shares)									14,921
Fair value as of grant date (in dollars per share)									$ 67.02
Remaining lives (Year)									1 year